Connect your AI

Relmada Therapeutics, Inc. RLMD Prepaid Legal

Other financials

Income statement

Operating income-$19.5M-6.8%

Net income-$19.1M-8.5%

EPS (diluted)-$0.22+62.1%

Balance sheet

Cash & equivalents$9.8M+750%

Total debt$104.1M-40.4%

Total equity$218.7M+875%

Total assets$235.4M+750%

Cash flow

Operating cash flow-$15.1M+16.6%

Valuation

Market cap$677.17M+2,907%

Returns & leverage

Return on equity-48.8%-20.0pp

Debt / equity0.9×0.0×

Current ratio18.3×+13.0×

Where this comes from

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept rlmd:PrepaidLegal.

The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relmada Therapeutics, Inc.'s prepaid legal.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Relmada Therapeutics, Inc.'s prepaid legal?: Relmada Therapeutics, Inc. (RLMD) reported prepaid legal of $143.4K in Q1 2026.